Incyte Corporation INCY
123.02
(1.80)
(1.44%)
as of 29 Sep
- Market cap
- $26.1B
- P/E
- 15.4×
Follow INCY
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
13.94 | 12.89 | 14.97 | 13.86 |
+8 more quarters Free account |
P/S ratio |
3.90 | 3.50 | 3.75 | 3.45 | |
P/FCF ratio |
12.02 | 13.20 | 14.50 | 14.16 | |
P/Operating CF |
44.74 | 50.80 | 35.49 | 29.67 | |
P/B ratio |
3.58 | 3.34 | 3.73 | 3.57 | |
Price to Tangible BV |
3.72 | 3.49 | 3.92 | 3.79 | |
EV/Sales |
3.13 | 2.76 | 3.06 | 2.85 | |
EV/EBITDA |
9.71 | 8.67 | 9.79 | 8.72 | |
EV/Operating CF |
9.20 | 9.75 | 11.13 | 10.95 | |
EV/FCF |
9.64 | 10.41 | 11.84 | 11.69 | |
Quick Ratio |
4.31 | 3.40 | 3.04 | 2.86 | |
Current Ratio |
4.59 | 3.68 | 3.32 | 3.20 | |
Net Debt/EBITDA |
(6.22) | (12.27) | (9.87) | (6.20) | |
Debt/Assets |
0.36% | 0.40% | 0.43% | 0.49% | |
Debt/Equity |
0.00 | 0.01 | 0.01 | 0.01 | |
Asset Turnover |
0.85 | 0.82 | 0.83 | 0.85 | |
Operating CF/Net income |
0.87 | 1.22 | 1.82 | 1.32 | |
Capex/Depreciation |
(0.47) | (0.64) | (0.91) | (1.65) | |
Interest Coverage |
1,199.14 | 529.20 | 577.08 | 749.19 | |
Research and Development Expense of Revenue |
30.88% | 40.54% | 40.57% | 37.09% | |
Selling, General and Administrative Expense of Revenue |
21.01% | 25.78% | 25.91% | 24.09% | |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.04 | 0.04 | |
Share Based Compensation of Revenue |
4.02% | 5.04% | 4.13% | 4.51% | |
Graham Net Nets |
0.20 | 0.20 | 0.17 | 0.16 | |
Graham Number |
76.10 | 68.07 | 62.70 | 57.21 | |
Earnings Yield |
7.17% | 7.76% | 6.68% | 7.22% | |
Free Cash Flow Yield |
8.32% | 7.57% | 6.90% | 7.06% | |
Revenue per Share |
8.35 | 6.38 | 7.72 | 6.98 | |
Operating CF per Share |
2.53 | 1.85 | 2.78 | 2.86 | |
Capex per Share |
(0.06) | (0.08) | (0.11) | (0.20) | |
Free Cash Flow per Share |
2.47 | 1.78 | 2.67 | 2.66 | |
Cash per Share |
22.64 | 20.15 | 18.34 | 14.97 | |
Shareholders Equity per Share |
31.66 | 28.21 | 26.47 | 23.77 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
31.66 | 28.21 | 26.47 | 23.77 | |
Free Cash Flow |
495.25 | 354.15 | 521.42 | 519.64 | |
Working Capital |
4,714.48 | 3,994.61 | 3,508.73 | 2,939.16 | |
Capital Expenditures |
(12.41) | (15.20) | (21.88) | (39.75) | |
Net Current Asset Value |
4,498.35 | 3,767.99 | 3,233.41 | 2,598.73 | |
EV/EBIT |
10.24 | 9.18 | 10.39 | 9.26 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.03 | |
Price to Operating Income |
12.77 | 11.65 | 12.73 | 11.21 | |
| Other line items | |||||
Average Receivables |
984.05 | 937.32 | 938.78 | 827.17 | |
Average Payables |
245.75 | 212.08 | 203.70 | 175.32 | |
Average Inventory |
97.98 | 89.80 | 79.97 | 76.94 | |
Average Assets |
6,847.00 | 6,544.24 | 6,201.15 | 5,671.40 | |
Average Common Equity |
5,257.67 | 4,645.21 | 4,307.55 | 3,911.21 |
Columns are period end dates